133 related articles for article (PubMed ID: 6195793)
1. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
[TBL] [Abstract][Full Text] [Related]
2. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
3. [Progress in the therapy of testicular teratoid tumors].
Seeber S
Wien Med Wochenschr; 1982 Jul; 132(13-14):329-33. PubMed ID: 6182701
[TBL] [Abstract][Full Text] [Related]
4. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Dunzendorfer U; Jurincic C
Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
6. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
[TBL] [Abstract][Full Text] [Related]
8. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
Wolf DJ; Williams JJ
Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
[No Abstract] [Full Text] [Related]
9. Immunohistochemistry of germ cell tumors of the testis. Study of beta HCG and AFP.
Caillaud JM; Bellet D; Carlu C; Droz JP
Prog Clin Biol Res; 1985; 203():139-40. PubMed ID: 2421327
[No Abstract] [Full Text] [Related]
10. [Diagnosis and therapy of malignant testicular neoplasms].
Douwes FR; Yu D; Truss F
Onkologie; 1978 Oct; 1(5):185-92. PubMed ID: 83558
[TBL] [Abstract][Full Text] [Related]
11. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
Zvara V; Hornák M; Breza J; Krídl J
Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
[TBL] [Abstract][Full Text] [Related]
12. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
[TBL] [Abstract][Full Text] [Related]
13. Residual retroperitoneal tumour tissue in patients treated for metastatic non-seminomatous testicular germ cell tumours: an immunohistochemical investigation.
Jacobsen GK; Olsen J
Tumour Biol; 1985; 6(1):25-35. PubMed ID: 2410971
[TBL] [Abstract][Full Text] [Related]
14. [Immunochemical demonstration of beta-HCG in a testicular tumor of the seminomatous type].
Carbone A; Caillaud JM
Pathologica; 1981; 73(1027):805-10. PubMed ID: 6176933
[No Abstract] [Full Text] [Related]
15. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
Javadpour N; Utz M; Soares T
J Urol; 1980 Nov; 124(5):615-6. PubMed ID: 6161257
[TBL] [Abstract][Full Text] [Related]
17. Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Fowler JE; Sesterhenn IA; Mostofi FK
Urology; 1989 Jan; 33(1):74-7. PubMed ID: 2463705
[TBL] [Abstract][Full Text] [Related]
18. Value of retroperitoneal lymphadenectomy after chemotherapy for non-seminomatous testicular tumor with lymph node metastases.
Le Guillou M; Ferriere JM; Brucher P; Mettetal PJ
Prog Clin Biol Res; 1989; 303():813. PubMed ID: 2780677
[No Abstract] [Full Text] [Related]
19. Cellular localization of AFP, hCG and its free subunits, and SP1 in embryonal carcinoma of the testis and ovary.
Furumoto M
Pathol Res Pract; 1981 Dec; 173(1-2):12-21. PubMed ID: 6174958
[TBL] [Abstract][Full Text] [Related]
20. Significance of radioimmunoassay of human chorionic gonadotropin and alpha fetoprotein in nonseminomatous germ cell tumors of the testis.
Kausitz J; Hupka S; Cerný V; Bohunický L; Korec S
Neoplasma; 1980; 27(3):321-7. PubMed ID: 6161314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
